Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jun 25:11:1411560.
doi: 10.3389/fnut.2024.1411560. eCollection 2024.

Artificial sweeteners and their implications in diabetes: a review

Affiliations
Review

Artificial sweeteners and their implications in diabetes: a review

Matcha Angelin et al. Front Nutr. .

Abstract

Diabetes is a significant global health concern, highlighting the critical role of dietary strategies in its management and prevention. Artificial sweeteners (ASs), due to their capacity to provide sweetness without contributing to caloric intake, have emerged as a potential tool in diabetes management. This review thoroughly examines the nuanced relationship between artificial sweeteners and diabetes, addressing their benefits and potential risks. ASs have been shown to aid in weight management, a key factor in reducing diabetes risk, and do not impact immediate blood glucose levels, offering improved glucose control for individuals with diabetes. Beyond these benefits, however, artificial sweeteners may interact complexly with gut microbiota, potentially altering its composition and affecting metabolic health. This interaction introduces concerns regarding insulin sensitivity and the risk of insulin resistance, with studies reporting conflicting findings. This comprehensive review highlights the importance of a nuanced approach to understanding the implications of artificial sweeteners in diabetes management. Given the mixed evidence on their health effects, there is a clear need for further research to fully elucidate the role of artificial sweeteners in metabolic health and their suitability as part of dietary interventions for diabetes.

Keywords: artificial sweeteners; diabetes mellitus; glucose; gut microbiota; sweeteners.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Types of sweeteners, advantages and disadvantages of natural and ASs.
Figure 2
Figure 2
Types and chemical structure of ASs.
Figure 3
Figure 3
Impact of ASs in glucose homeostasis. Created with BioRender.com.

References

    1. Sun H, Saeedi P, Karuranga S, Moritz Pinkepank, Ogurtsova K, Bruce B. Duncan, et al. IDF diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. (2021) 183:109119. 10.1016/j.diabres.2021.109119 - DOI - PMC - PubMed
    1. Pradeepa R, Mohan V. Prevalence of type 2 diabetes and its complications in India and economic costs to the nation. Eur J Clin Nutr. (2017) 71:816–24. 10.1038/ejcn.2017.40 - DOI - PubMed
    1. Sapra A, Bhandari P. Diabetes. StatPearls. Treasure Island (FL): StatPearls Publishing. (2023). Available online at: http://www.ncbi.nlm.nih.gov/books/NBK551501/
    1. Khan MAB, Hashim MJ, King JK, Govender RD, Mustafa H, Al Kaabi J. Epidemiology of type 2 diabetes – global burden of disease and forecasted trends. J Epidemiol Glob Health. (2020) 10:107–11. 10.2991/jegh.k.191028.001 - DOI - PMC - PubMed
    1. Debras C, Esseddik Y, de Edelenyi FS, Kesse-Guyot E, Alle B, Tatulashvili S, et al. Artificial sweeteners and risk of type 2 diabetes in the prospective NutriNet-Sante cohort. Diabetes Care. 46:1681–90. 10.2337/dc23-0206 - DOI - PMC - PubMed

LinkOut - more resources